EcoDrugPlus

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSSMAG00000019186
Gene Symbol: TRHRB
3 Cross references
193 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSSMAG00000002367
Gene Symbol: TLR2
1 Cross references
183 Possible Orthologues:

Toll-Like Receptor 2

Ensembl ID : ENSSMAG00000016802
Gene Symbol: TLR2
3 Cross references
213 Possible Orthologues:

Toll-Like Receptor 8

Ensembl ID : ENSSMAG00000017362
Gene Symbol: LOC118282535
3 Cross references
197 Possible Orthologues:

Trace Amine-Associated Receptor 1-Like

Ensembl ID : ENSSMAG00000024699
Gene Symbol: LOC118290331
2 Cross references
378 Possible Orthologues:

Trace Amine-Associated Receptor 4-Like

Ensembl ID : ENSSMAG00000025430
Gene Symbol: LOC118290319
2 Cross references
363 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSSMAG00000004426
Gene Symbol: TGFBR1B
1 Cross references
204 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSSMAG00000016269
Gene Symbol: TRPA1B
1 Cross references
200 Possible Orthologues:

Transthyretin (Prealbumin, Amyloidosis Type I)

Ensembl ID : ENSSMAG00000018650
Gene Symbol: TTR
2 Cross references
178 Possible Orthologues:

Trithorax Group Protein Osa

Ensembl ID : ENSSMAG00000021177
Gene Symbol: SI:CH211-79M20.1
2 Cross references
190 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSSMAG00000012969
Gene Symbol: TPH1A
3 Cross references
207 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSSMAG00000008348
Gene Symbol: TTK
3 Cross references
204 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).